Tenax Therapeutics (TENX) Other Non Operating Income (2011 - 2026)
Tenax Therapeutics (TENX) reported Other Non Operating Income of -$4000.0 for Q1 2026, up 55.56% sequentially from -$9000.0 in Q4 2025.
Tenax Therapeutics (TENX) Other Non Operating Income (2011 - 2026) Analysis & Trends
Tenax Therapeutics (TENX) has 15 years of Other Non Operating Income data on file, last reported at -$4000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income changed N/A year-over-year to -$4000.0; the trailing twelve-month figure through Mar 2026 stood at -$37000.0 (down 1494.12% YoY), and the FY2025 full-year result was -$33000.0, down 3400.0% from the prior year.
- Other Non Operating Income improved to -$4000.0 in Q1 2026, from -$9000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $125866.0 in Q4 2023 to a low of -$140055.0 in Q1 2023.
- A 5-year average of -$12442.9 and a median of -$3146.0 in 2022 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 2261.53% in 2023, while the deepest fall reached 45279.03% in 2023.
- Tracing TENX's Other Non Operating Income over 5 years: stood at -$5823.0 in 2022, then surged by 2261.53% to $125866.0 in 2023, then tumbled by 98.69% to $1654.0 in 2024, then plunged by 644.14% to -$9000.0 in 2025, then surged by 55.56% to -$4000.0 in 2026.
- Business Quant data shows TENX's Other Non Operating Income at -$4000.0 in Q1 2026, -$9000.0 in Q4 2025, and -$15000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Sep 30, 2025 | -15,000.00 |
| Jun 30, 2025 | -9,000.00 |
| Dec 31, 2024 | 1,654.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | -117,449.00 |
| Dec 31, 2023 | 125,866.00 |
| Jun 30, 2023 | 911.00 |
| Mar 31, 2023 | -140,055.00 |
| Dec 31, 2022 | -5,823.00 |
| Sep 30, 2022 | -1,323.00 |
| Jun 30, 2022 | -2,292.00 |
| Mar 31, 2022 | 310.00 |
| Dec 31, 2021 | 1,235.00 |
| Sep 30, 2021 | 3,642.00 |
| Jun 30, 2021 | -247,820.00 |
| Mar 31, 2021 | -2,135.00 |
| Dec 31, 2020 | 32,204.00 |
| Sep 30, 2020 | -5,298.00 |